41 / 46
3. Largos respondedores
con Pazopanib
•
Características basales asociadas a larga respuesta:
•
ECOG= 0 basal (42.4% vs. 18.3%, p=0.004)
•
Nefrectomía previa (81.8% vs. 57.5%, p=0.010).
Park, J; Jiao, X; Wilson, T. Predictors of long-term responders in patients treated with pazopanib for advanced renal cell carcinoma (aRCC).
Journal of Clinical Oncology, supl. Supplement 1 35.6 American Society of Clinical Oncology. 2017.